Congress
Northeast GI Oncology Congress 2026
Overview
Venue
The Royal Sonesta Boston
40 Edwin Land Boulevard
Cambridge, MA 02142, USA
Date / Time
Nov 19, 2026 – Nov 20, 2026
Save to
The whole field, in one conversation.
GI oncology is moving quickly across biomarkers, targeted therapies, immunotherapy, liquid biopsy, and new treatment modalities. NEGI 2026 is designed to connect those advances across disease areas—and to keep the patient perspective in the room.
The program moves from bench science and emerging investigators to multidisciplinary clinical practice, access, equity, quality of life, and patient-partnered research. Every participant shares the same track, creating space for ideas to travel across specialties.
Partners
Congress Leadership
Meet the Congress Leadership
Dr. Yelena Janjigian is Chief of the Gastrointestinal Oncology Service and the Carroll and Milton Petrie Chair at Memorial Sloan Kettering Cancer Center. A physician-scientist specializing in esophageal and stomach cancers, she leads clinical and translational research focused on biomarker-directed treatment, immunotherapy, and the development of new therapeutic strategies for upper GI malignancies.
Dr. Samuel Klempner is a gastrointestinal medical oncologist at Massachusetts General Hospital. His work uses molecular characterization to individualize care across GI cancers, with particular emphasis on gastroesophageal malignancies. He leads clinical trials and translational research evaluating targeted agents, immune therapies, and the mechanisms that shape treatment response and resistance.
Dr. Aparma R. Parikh is a gastrointestinal medical oncologist at Massachusetts General Hospital and Medical Director of the Center for Young Adult Colorectal Cancer. Her clinical and research work centers on colorectal cancer, including young-onset disease, liquid biopsy, and novel therapeutic approaches. She also directs Mass General’s Global Cancer Care Program, advancing equitable access to cancer care and technology.
Dr. Eileen O’Reilly is the Winthrop Rockefeller Endowed Chair of Medical Oncology at Memorial Sloan Kettering Cancer Center. She is Co-Director for Medical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer Research and Section Head of Hepatopancreatobiliary and Neuroendocrine Cancers. Her work focuses on pancreatic and hepatobiliary malignancies, including molecularly and genetically informed treatment strategies.
Ms. Martha Raymond is the Founder and CEO of the GI Cancers Alliance and The Raymond Foundation. She has more than four decades of experience advocating for cancer patients and caregivers. Her work focuses on patient education, advocacy, and research into patient-reported outcomes, ensuring that patients’ voices and lived experiences inform cancer care. She also develops oncology programs in collaboration with academic institutions, industry, and global advocacy organizations.
Scientific Program
Day One
The Patient at the Table — Thursday, November 19, 2026
| 10:30 AM | Coffee |
| 10:45 AM | Welcome and Congress Opening |
| 11:00 AM | Patient Advocacy Plenary: Patient-Partnered Research in GI Cancer |
| 11:45 AM | Upper GI Case-Based Tumor Board |
| 12:30 PM | Break |
| 12:45 PM | When Less Is Better: Quality of Life and Treatment Burden |
| 1:30 PM | Meet the Chairs: Designing a GI Trial That Matters |
| 2:15 PM | Networking Lunch |
| 3:15 PM | In Five Years, Most Adjuvant Therapy Will Be Guided by What? |
| 4:15 PM | GI Research Rapid-Fire with Investigators and Patient Advocates |
| 5:00 PM | Day One Closing |
Day Two
The Whole Field, One Room — Friday, November 20, 2026
| 8:00 AM | Coffee and Mentorship Tables |
| 8:30 AM | Scientific Opening and the State of GI Oncology |
| 8:45 AM | New Treatments in GI Cancer: What They Mean for Patients |
| 9:30 AM | Gastroesophageal Cancer: Choosing Between Targets |
| 10:30 AM | Break |
| 10:45 AM | ctDNA and MRD: What Should Change Practice? |
| 11:30 AM | Biopharma Science Rapid-Fire |
| 12:15 PM | Networking Lunch |
| 1:30 PM | Pancreas and Biliary: From Biology to the Clinic |
| 3:00 PM | Break |
| 3:15 PM | Colorectal Cancer: New Targets and New Decisions |
| 4:30 PM | Lessons That Travel Across GI Cancers |
| 5:00 PM | Awards, Closing, and Farewell Reception |
Partnership Opportunities
Partnership & Collaboration Opportunities
Shushan Hovsepyan
Senior Vice President, OncoDaily
Email: shushan.hovsepyan@oncodaily.com
Phone: +1 571 775 9710
Event-Related Inquiries
Inessa Mkhitaryan
Head of Global Events, OncoDaily
Email: inessa.mkhitaryan@oncodaily.com
General Inquiries
Email: info@oncodaily.com
